ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,263, issued on Dec. 9, was assigned to Genentech Inc. (South San Francisco, Calif.).
"Anti-HER2 antibodies and immunoconjugates" was invented by Xiaocheng Chen (Burlingame, Calif.), Mark Dennis (San Carlos, Calif.), Jagath Reddy Junutula (Fremont, Calif.), Gail Lewis Phillips (San Carlos, Calif.), Thomas Harden Pillow (San Francisco) and Mark X. Sliwkowski (San Carlos, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides anti-HER2 antibodies and immunoconjugates and methods of using the same."
The patent was filed on April 14, 2022, under Application No. 17/720,717.
*For further information, including images, charts and tabl...